Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Clinical trial NCT00111839 · COMPLETED

Trial details

NCT number: NCT00111839
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non Small Cell Lung Carcinoma

Start date: 2005-05-31
Primary completion: 2007-07-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.